Simple and Effective Generation of Cell-based Assays for Ion Channels, Transporters, and Kinase Screening in Biologically Relevant Cells Using Scalable Transient Transfection

14 Aug 2014

This poster demonstrates that MaxCyte electroporation provides an extremely effective and flexible means of co-transfecting multiple plasmids to construct a variety of receptors and other assay targets, including GPCRs, ion channels, transporters, and kinases. The MaxCyte STX® Scalable Transfection System uses proprietary flow electroporation to transiently transfect from 5E5 cells in seconds up to 2E10 cells in less than 30 minutes, yielding high levels of transfection efficiency and cell viability. The technology is applicable to a wide range of cell types, including primary cells and stem cells. This poster presents MaxCyte transient-transfected assays including a CFTR transporter assay, a HCS casein kinase assay, and ion channel assays. The results demonstrate that MaxCyte transfection provides a rapid and robust means for conducting cell-based assay screening.

Links

Tags

Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.ElectroporationTransfectionTransfection introduces nucleic acids (DNA or RNA) into cells, facilitating gene expression, genome editing, and functional studies. It�s widely used in genetic research, drug discovery, and therapeutic development. Find transfection reagents, kits, and systems in our product directory with reviews and pricing options.Assay DevelopmentThe process of proving an assay to be sensitive with respect to the target is known as assay development. The assay should be able to characterize novel compounds and measure the potency of these compounds against a validated biological target.